Gastroesophageal Reflux Disease (GERD) & Acid Peptic Disease

Editor's Choice

A strategy for GERD and Barrett's esophagus

Chronic gastroesophageal reflux disease in older patients is a risk factor for Barrett's esophagus, and anyone potentially at risk for this predominant precursor to esophageal adenocarcinoma should be referred to a gastroenterologist.

LATEST ARTICLES

A strategy for GERD and Barrett's esophagus

Preferential formulary listing of a proton-pump inhibitor (PPI): Compliance with policy in a Canadian military population

In 2003, the Canadian Forces (CF) drug benefit plan used preferential listing to control costs associated with proton pump inhibitors (PPIs); however, significant expenditures for nonbenefit PPIs continued. A database review was thus conducted to explain this anomalous usage pattern. This study provides further information regarding the effectiveness of preferred listing as a cost-saving measure, noting that adherence to such policies may be less than projected.

Antacid sales top $10 billion annually

Information on OTC indigestion remedies that pharmacists can use to brief patients

Study: Nonpharmacologic therapy improves infant GERD symptoms

The benefits of nonpharmacologic therapy for infant GERD.

Chronic Cough: Seeking the Cause and the Solution

In the vast majority of nonsmokers who are not receiving angiotensin converting-enzyme inhibitors and who have no evidence of active disease on chest radiographs, chronic cough is caused by postnasal drip syndrome (recently renamed upper airway cough syndrome [UACS]), asthma, non-asthmatic eosinophilic bronchitis, or gastroesophageal reflux disease (GERD), alone or in combination.